In April of 2002, the FDA assesses the application but declines to approve it. The federal government company intends to see even more clinical studies, the resolution of some production issues as well as the complete labeling of the product.
In May of that year, Lilly ICOS reports that Phase III examination results for Cialis are positive. Data show that Cialis remains in the man’s system for up to 36 hrs, supplying a bigger window for sex than with Viagra. These searchings for exist in Orlando, Florida to the 97th meeting of the American Urological Association.
Meanwhile, in July 2002, the European Committee of Proprietary Medicinal Products recommends the approval of the medicine in Europe. Authorization can be found in November of 2002 for European sales, cialisskr.com with advertising of the item adhering to in February 2003.